Real-Time ctDNA Monitoring for ESR1 Mutations in ER+ Breast Cancer | 0.25-hour CME/CE | On-Demand Video Podcast | Watch or Listen In Today! #MedEd #cme #BreastCancer | bit.ly/4fIT7kb
PRIME Education
Verified account This account is verified. Learn more@PRIME_cme
PRIME is a healthcare education and research company advancing the science of learning and behavior change for 30 years. primece.com
1.3K Following 466 Followers 5K Posts
Latest posts 5
Clinical Data and Expert Perspectives on Emerging Bispecific ADCs in Urothelial Carcinoma | 0.25-hour CME/CE | Clinical Mic Drop, Bispecific ADC SynopsiMedEd™ Interface | Get Updated Today!
#MedEd #cme #BladderCancer | bit.ly/45WRWr5
#MedEd #cme #BladderCancer | bit.ly/45WRWr5
Just Released | Risk Stratification and Tailoring Treatment in HER2+ Early Breast Cancer | 0.5-hour CME/CE | On-Demand Video Podcast #1 of 2 | Watch or Listen on the Go! #MedEd #cme #BreastCancerTreatment | bit.ly/4pKMTDq
New treatment approaches for Spinal Muscular Atrophy | Navigating SMA Management: From Disease-Modifying Therapies to Lifelong Care | 0.75-hour CME/CE | On-Demand Video #2 of 2 | #MedEd #cme #SpinalMuscularAtrophy #SMATreatment | bit.ly/4zxbdNk
Recognizing Recurrent MI Risk: Identifying High-Risk Patients and Clinical Consequences | 0.25-hour CME/CE | On-Demand Video #1 of 3, Recurrent Myocardial Infarction I Micro-Learning Series | Get Updated--Join Us Today! #MedEd #cme # myocardialinfarction | bit.ly/4wSU5j1
